Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$151 Hold
10
﹤0.01% 2203
2025
Q4
$126 Sell
10
-95
-90% -$1.4K ﹤0.01% 1957
2025
Q3
$1.61K Buy
105
+95
+950% +$1.53K ﹤0.01% 1853
2025
Q2
$167 Hold
10
﹤0.01% 1889
2025
Q1
$189 Hold
10
﹤0.01% 1844
2024
Q4
$238 Hold
10
﹤0.01% 1855
2024
Q3
$271 Hold
10
﹤0.01% 1784
2024
Q2
$270 Buy
+10
New +$208 ﹤0.01% 1804
2024
Q1
Sell
-10
Closed -$225 1917
2023
Q4
$225 Hold
10
﹤0.01% 1627
2023
Q3
$195 Hold
10
﹤0.01% 1645
2023
Q2
$228 Sell
10
-300
-97% -$6.04K ﹤0.01% 1683
2023
Q1
$7.45K Sell
310
-300
-49% -$5.76K ﹤0.01% 1288
2022
Q4
$10.5K Buy
+610
New +$10.8K ﹤0.01% 1205

Other funds holding RXO

TD Waterhouse Canada's RXO Position: Q1 2026 in Review

TD Waterhouse Canada held its RXO (RXO) position steady in Q1 2026 at 10 shares worth $151. The position accounts for ﹤0.01% of the portfolio, ranked #2203.

TD Waterhouse Canada first reported a position in RXO in Q4 2022 and has held it in 13 quarters since. The position peaked at $10.5K in Q4 2022. 274 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

  • TD Waterhouse Canada held 10 shares of RXO worth $151 as of Q1 2026.
  • TD Waterhouse Canada left its RXO share count unchanged in Q1 2026.
  • RXO made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #2203 holding.
  • TD Waterhouse Canada first reported a position in RXO in Q4 2022 and has held it in 13 quarters since.
  • TD Waterhouse Canada's RXO position peaked at $10.5K in Q4 2022.
  • 274 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.